Mini Review
Published on 14 Jan 2021
Prenatal Cannabinoid Exposure: Emerging Evidence of Physiological and Neuropsychiatric Abnormalities
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2020.624275
- 32,650 views
- 50 citations
Type at least 3 characters
531 articles
Articles
Case Report
Published on 08 Jan 2021
Case Report: Paliperidone Palmitate in the Management of Bipolar I Disorder With Non-compliance
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2020.529672
- 5,754 views
- 1 citation
Opinion
Published on 23 Dec 2020
Chlorpromazine as a Potential Antipsychotic Choice in COVID-19 Treatment
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2020.612347
- 6,768 views
- 11 citations
Review
Published on 23 Dec 2020
Pharmacotherapy of Anxiety Disorders: Current and Emerging Treatment Options
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2020.595584
- 360,409 views
- 222 citations
Original Research
Published on 10 Dec 2020
Adjunct Therapy With Glycyrrhiza Glabra Rapidly Improves Outcome in Depression—A Pilot Study to Support 11-Beta-Hydroxysteroid Dehydrogenase Type 2 Inhibition as a New Target
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2020.605949
- 4,853 views
- 10 citations
Original Research
Published on 08 Dec 2020
Nationwide Study of Neuropsychiatric Comorbidity and Medicines Use in Children With Autism Spectrum Disorder in Norway
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2020.596032
- 3,769 views
- 6 citations
Review
Published on 27 Nov 2020
Curcumin in Depression: Potential Mechanisms of Action and Current Evidence—A Narrative Review
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2020.572533
- 62,736 views
- 68 citations
Review
Published on 19 Nov 2020
Glutamate Systems in DSM-5 Anxiety Disorders: Their Role and a Review of Glutamate and GABA Psychopharmacology
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2020.548505
- 35,827 views
- 49 citations
Clinical Trial
Published on 13 Nov 2020
Effects of Cannabidiol and Delta-9-Tetrahydrocannabinol on Emotion, Cognition, and Attention: A Double-Blind, Placebo-Controlled, Randomized Experimental Trial in Healthy Volunteers
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2020.576877
- 35,674 views
- 26 citations
Original Research
Published on 12 Nov 2020
Sex-Specific Associations Between Bipolar Disorder Pharmacological Maintenance Therapies and Inpatient Rehospitalizations: A 9-Year Swedish National Registry Study
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2020.598946
- 3,097 views
- 6 citations
Original Research
Published on 12 Nov 2020
Adolescent Δ9-Tetrahydrocannabinol Exposure Selectively Impairs Working Memory but Not Several Other mPFC-Mediated Behaviors
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2020.576214
- 4,018 views
- 13 citations
Opinion
Published on 03 Nov 2020
Antipsychotic-Induced Weight Gain and Clinical Improvement: A Psychiatric Paradox
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2020.560006
- 3,495 views
- 10 citations
Review
Published on 30 Oct 2020
Are CB2 Receptors a New Target for Schizophrenia Treatment?
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2020.587154
- 8,873 views
- 23 citations
Original Research
Published on 29 Oct 2020
Jie-Yu Pill, A Proprietary Herbal Medicine, Ameliorates Mood Disorder-Like Behavior and Cognitive Impairment in Estrogen-Deprived Mice Exposed to Chronic Unpredictable Mild Stress: Implication for a Potential Therapy of Menopause Syndrome
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2020.579995
- 5,558 views
- 11 citations
Systematic Review
Published on 23 Oct 2020
A Systematic Review of Efficacy, Safety, and Tolerability of Duloxetine
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2020.554899
- 54,654 views
- 46 citations
Case Report
Published on 22 Oct 2020
Treatment of a Complex Personality Disorder Using Repeated Doses of LSD—A Case Report on Significant Improvements in the Absence of Acute Drug Effects
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2020.573953
- 63,937 views
- 11 citations